Decrease of plasma platelet-activating factor acetylhydrolase activity in lipopolysaccharide induced Mongolian gerbil sepsis model

PLoS ONE

Volumn 5, Issue 2, 2010, Pages

  Yang, Junwei ^a   Xu, Jing ^b,c   Chen, Xiaoying ^d   Zhang, Yixuan ^d   Jiang, Xucheng ^c   Guo, Xiaokui ^c   Zhao, Guoping ^a,e,f  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^e INSTITUTE OF PLANT PHYSIOLOGY AND ECOLOGY   (China)

^f CHINESE NATIONAL HUMAN GENOME CENTER AT SHANGHAI   (China)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; LIPOPOLYSACCHARIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; GERBIL; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; SEPSIS; ANIMAL; BLOOD; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; ENZYME ASSAY; HUMAN; METABOLISM; SPECIES DIFFERENCE;

MERIONES UNGUICULATUS; MESOCRICETUS AURATUS; MUS; RATTUS; RODENTIA;

1-ALKYL-2-ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ANIMALS; DISEASE MODELS, ANIMAL; ENZYME ASSAYS; GERBILLINAE; HUMANS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; SEPSIS; SPECIES SPECIFICITY;

EID: 77949426224     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009190     Document Type: Article

References (22)

1. Chao W, Olson MS (1993) Platelet-activating factor: receptors and signal transduction. Biochem J 292 (Pt 3): 617-629.
2. Marshall JC (2003) Such stuff as dreams are made on: mediator-directed therapy in sepsis. Nat Rev Drug Discov 2: 391-405.
3. Zimmerman GA, McIntyre TM, Prescott SM, Stafforini DM (2002) The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis. Crit Care Med 30: S294-301.
4. Chang SW, Feddersen CO, Henson PM, Voelkel NF (1987) Platelet-activating factor mediates hemodynamic changes and lung injury in endotoxin-treated rats. J Clin Invest 79: 1498-1509.
5. Jeong YI, Jung ID, Lee CM, Chang JH, Chun SH, et al. (2009) The novel role of platelet-activating factor in protecting mice against lipopolysaccharide-induced endotoxic shock. PLoS One 4: e6503.
6. Stafforini DM, McIntyre TM, Zimmerman GA, Prescott SM (1997) Plateletactivating factor acetylhydrolases. J Biol Chem 272: 17895-17898.
7. Graham RM, Stephens CJ, Silvester W, Leong LL, Sturm MJ, et al. (1994) Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit Care Med 22: 204-212.
8. Yang J, Zhang Y, Xu J, Geng Y, Chen X, et al. (2009) Serum activity of plateletactivating factor acetylhydrolase is a potential clinical marker for leptospirosis pulmonary hemorrhage. PLoS ONE 4: e4181.
9. Gomes RN, Bozza FA, Amancio RT, Japiassu AM, Vianna RC, et al. (2006) Exogenous platelet-activating factor acetylhydrolase reduces mortality in mice with systemic inflammatory response syndrome and sepsis. Shock 26: 41-49.
10. Claus RA, Russwurm S, Dohrn B, Bauer M, Losche W (2005) Plasma plateletactivating factor acetylhydrolase activity in critically ill patients. Crit Care Med 33: 1416-1419.
11. Partrick DA, Moore EE, Moore FA, Biffl WL, Barnett CC (1997) Reduced PAFacetylhydrolase activity is associated with postinjury multiple organ failure. Shock 7: 170-174.
12. Cao Y, Stafforini DM, Zimmerman GA, McIntyre TM, Prescott SM (1998) Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. J Biol Chem 273: 4012-4020.
13. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, et al. (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
14. Memon RA, Fuller J, Moser AH, Feingold KR, Grunfeld C (1999) In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am J Physiol 277: R94-103.
15. Howard KM, Olson MS (2000) The expression and localization of plasma platelet-activating factor acetylhydrolase in endotoxemic rats. J Biol Chem 275: 19891-19896.
16. Svetlov SI, Sturm E, Olson MS, Crawford JM (1999) Hepatic regulation of platelet-activating factor acetylhydrolase and lecithin:cholesterol acyltransferase biliary and plasma output in rats exposed to bacterial lipopolysaccharide. Hepatology 30: 128-136.
17. Howard KM, Miller JE, Miwa M, Olson MS (1997) Cell-specific regulation of expression of plasma-type platelet-activating factor acetylhydrolase in the liver. J Biol Chem 272: 27543-27548.
18. Buras JA, Holzmann B, Sitkovsky M (2005) Animal models of sepsis: setting the stage. Nat Rev Drug Discov 4: 854-865.
19. Fink MP (2008) Animal models of sepsis and its complications. Kidney Int 74: 991-993.
20. Metzler MB, Robert Schuster, Daniel Slotman, Gus Michael, John Zimmerman, Janice, et al. (1999) An evaluation of recombinant human platelet activating factor acetylhydrolase (rPAF-AH) in patients at risk for developing acute respiratory distress syndrome. Critical Care Medicine Volume 27: p85A.
21. Schuster DP, Metzler M, Opal S, Lowry S, Balk R, et al. (2003) Recombinant platelet-activating factor acetylhydrolase to prevent acute respiratory distress syndrome and mortality in severe sepsis: Phase IIb, multicenter, randomized, placebo-controlled, clinical trial. Crit Care Med 31: 1612-1619.
22. Opal S, Laterre PF, Abraham E, Francois B, Wittebole X, et al. (2004) Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial. Crit Care Med 32: 332-341.